Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
AEZS-120
print preview
bookmark
share with colleague
General Information
Company
Aeterna Zentaris Inc.
Description
Live, recombinant Salmonella typhi Ty21a-based oral vaccine expressing prostate-specific antigen (KLK3; PSA fused to the B subunit of cholera toxin
Molecular Target
Not applicable
Mechanism of Action
Vaccine
Latest Stage of Development
Preclinical
Indication
Prostate cancer
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy